한국형 우울장애 약물치료 알고리듬 2017(V) : 소아·청소년/노인/여성

초록

vision of the previous version. The main purpose of the current study was an amendment of the guidelines for the treatment of major depressive disorder (MDD) for a special population. Methods : The survey consisted of 11 questionnaires for children and adolescents, 7 questionnaires for the elderly, and 8 questionnaires for females. A total of 24 of the 42 experts in pediatric psychiatry, and 79 of the 144 experienced adult psychiatrists answered the survey. Results : As the 1st line of treatment for MDD without psychotic features in children and adolescents, antidepressant (AD) monotherapy was the preferred choice, and AD augmented with atypical antipsychotics (AAP) was preferred for MDD with psychotic features. In geriatric depression, AD monotherapy was recommended as the treatment of choice for mild to moderate episodes and for severe episodes without psychotic features. For the latter, combination of AD and AAP was recommended as the treatment of choice. For MDD in pregnancy, AD monotherapy was as the preferred 1st line in both mild to moderate and severe episodes without psychotic features. In severe episode with psychotic features, a combination of AD and AAP was selected as the 1st line option. Conclusion : We developed the algorithm for special populations with depressive disorders, more specifically than the KMAP-DD 2012. We expect this algorithm will provide clinicians useful information and help the treatment of children and adolescents with depressive disorders

키워드